Bioactive Compounds
-
M1301 azelate (nonanedioate)Summary: A topical formulation that inhibits acne-causing bacteria and reduces hyperpigmentation. -
C8882 PamabromSummary: A diuretic that acts on the opioid receptor-NO-cGMP-K+ channel pathway to produce peripheral analgesia, used for the treatment of premenstrual syndrome and primary dysmenorrhea -
N1794 Liquiritin -
BA1157 BrilacidinSummary: Brilacidin (PMX30063) is an antimicrobial agent. -
BA3113 DesacetylcinobufotalinSummary: Desacetylcinobufotalin is an apoptosis inducer. -
C3154 Hydrocortisone 21-hemisuccinate (sodium salt)Summary: An orally active, GR-mediated anti-inflammatory glucocorticoid derivative. -
C3401 5-FAM SESummary: A fluorescent reagent for intracellular labeling of peptides and nucleotides -
M1297 3-hydroxybutyrate (BHBA)1 CitationSummary: An endogenous ketone body metabolite involved in lipid metabolism and research on diabetes mechanisms. -
BA1156 RNPA1000Summary: RNPA1000 is an antibiotic, a potent inhibitor of RnpA-mediated cellular RNA degradation. -
BA3112 M47Summary: M47 is a small molecule that selectively destabilizes cryptorchidin 1 (CRY1) and increases the degradation of CRY1 in the nucleus.

